Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review.
New Eczematous Eruption in Patients With Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review.
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review. J Crohns Colitis. 2025 Jul 03; 19(7).
View in:
PubMed
subject areas
Clinical Trials as Topic
Colitis, Ulcerative
Europe
Humans
Practice Guidelines as Topic
United States
United States Food and Drug Administration
authors with profiles
David Rubin